is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
23 January 2018
A pioneering food supplement that protects the eye from damage caused by diabetes will be showcased in the Middle East for the first time at Arab Health 2018.
Being unveiled by British pharmaceutical wholesaler and distributor, CHAPPER healthcare (formerly Philip Chapper & Company Ltd), RetiCap® provides preventative support for patients with diabetic retinopathy.
Easy to swallow, the capsule offers a natural protection and concentrates on the increased need for nutrients for the eye caused by diabetes. RetiCap® contains vitamin B1, the flavonoid Rutin, as well as Alpha-lipoic acid. The micronutrients help to stabilise and disrupt any damage caused to the eye by diabetes.
Philip Chapper & Company Ltd was established over 40 years ago and has a worldwide reputation for successfully sourcing and distributing pharmaceutical products globally. The company has recently rebranded as CHAPPER healthcare, a change of name that reflects the wider changes taking place across the organisation.
CHAPPER healthcare are looking forward to sharing their new branding with long standing Middle Eastern partners and customers, as well as with new contacts.
CEO Jonathan Chapper, explains: “The Middle East is one of our key markets and we invest a lot of time and resource into building relationships here. It’s so important for us to come to Arab Heath to showcase new products and highlight the developments that have taken place within our company over the last year. Our new image reflects our heritage, but enables us to look to the future. We are a modern company who is focused on improving healthcare and access to medicines in the Middle East.”
Also on display on the CHAPPER healthcare stand will be a range of other products available for exclusive distribution. These will include Vitrocap® for vitreous floaters and Macu-Save™, an easy-to-swallow supplement that offers added protection against macular degeneration, the leading cause of severe vision loss in people over 60 as well as other food supplements and medical devices.
CHAPPER healthcare source and distribute products, consolidate orders and organise shipments, to 6 continents worldwide. They supply branded and generic pharmaceuticals including orphan drugs, over the counter medicines, veterinary medicines and other medical supplies.
Whether it’s a small one-off shipment or the delivery of several containers, the company’s multilingual team pride themselves on delivering exceptional customer service and supplying products safely, securely and on time. The team are fully aware that there is always a patient at the centre of every request.
Arab Health 2018 is taking place from 29th January to the 1st February 2018, at the Dubai Convention and Exhibition Centre. The CHAPPER healthcare stand will be located on the UK Pavilion Hall 7, Stand B18
Notes to Editors
About Chapper Healthcare
Formerly Philip Chapper & Company Limited, Chapper healthcare is a world class medical supplies wholesaler and distributor, specialising in importing and exporting pharmaceuticals and medical supplies to markets across the globe.
Established in 1975, the company are experts at sourcing products, consolidating orders and organising shipments, to any destination. Their customers include government ministries, hospitals, clinics, pharmacy chains, health professionals and medical distributors. For more information please visit www.chapperhealthcare.com
To request an interview with Jonathan Chapper please contact Julia Price:
DD: +44 (0) 7737 864878